54 related articles for article (PubMed ID: 15634634)
1. [Expression of the p56lck by colon tumors: a marker of their invasive capacity?].
Rouer E
Bull Cancer; 2004 Dec; 91(12):928-40. PubMed ID: 15634634
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
[TBL] [Abstract][Full Text] [Related]
3. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
[TBL] [Abstract][Full Text] [Related]
4. Translational activation of the lck proto-oncogene.
Marth JD; Overell RW; Meier KE; Krebs EG; Perlmutter RM
Nature; 1988 Mar; 332(6160):171-3. PubMed ID: 3347254
[TBL] [Abstract][Full Text] [Related]
5. Activating SRC mutation in a subset of advanced human colon cancers.
Irby RB; Mao W; Coppola D; Kang J; Loubeau JM; Trudeau W; Karl R; Fujita DJ; Jove R; Yeatman TJ
Nat Genet; 1999 Feb; 21(2):187-90. PubMed ID: 9988270
[TBL] [Abstract][Full Text] [Related]
6. [Neuronal isoforms of Src, Fyn and Lck tyrosine kinases: A specific role for p56lckN in neuron protection].
Rouer E
C R Biol; 2010 Jan; 333(1):1-10. PubMed ID: 20176329
[TBL] [Abstract][Full Text] [Related]
7. Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines.
Veillette A; Foss FM; Sausville EA; Bolen JB; Rosen N
Oncogene Res; 1987; 1(4):357-74. PubMed ID: 2835736
[TBL] [Abstract][Full Text] [Related]
8. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits.
Pelchen-Matthews A; Boulet I; Littman DR; Fagard R; Marsh M
J Cell Biol; 1992 Apr; 117(2):279-90. PubMed ID: 1373141
[TBL] [Abstract][Full Text] [Related]
9. SRC gene expression in human cancer: the role of transcriptional activation.
Dehm SM; Bonham K
Biochem Cell Biol; 2004 Apr; 82(2):263-74. PubMed ID: 15060621
[TBL] [Abstract][Full Text] [Related]
10. CAML is a p56Lck-interacting protein that is required for thymocyte development.
Tran DD; Edgar CE; Heckman KL; Sutor SL; Huntoon CJ; van Deursen J; McKean DL; Bram RJ
Immunity; 2005 Aug; 23(2):139-52. PubMed ID: 16111633
[TBL] [Abstract][Full Text] [Related]
11. Retinal dysplasia in mice lacking p56lck.
Omri B; Blancher C; Neron B; Marty MC; Rutin J; Molina TJ; Pessac B; Crisanti P
Oncogene; 1998 May; 16(18):2351-6. PubMed ID: 9620552
[TBL] [Abstract][Full Text] [Related]
12. The carboxy-terminal sequence of p56lck can regulate p60c-src.
MacAuley A; Cooper JA
Mol Cell Biol; 1988 Aug; 8(8):3560-4. PubMed ID: 2463478
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression.
Samraj AK; Stroh C; Fischer U; Schulze-Osthoff K
Oncogene; 2006 Jan; 25(2):186-97. PubMed ID: 16116473
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Bcl-3 through interaction with the Lck tyrosine kinase.
Zhao Y; Ramakrishnan A; Kim KE; Rabson AB
Biochem Biophys Res Commun; 2005 Sep; 335(3):865-73. PubMed ID: 16099425
[TBL] [Abstract][Full Text] [Related]
15. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells.
Gouyer V; Fontaine D; Dumont P; de Wever O; Fontayne-Devaud H; Leteurtre E; Truant S; Delacour D; Drobecq H; Kerckaert JP; de Launoit Y; Bracke M; Gespach C; Desseyn JL; Huet G
Oncogene; 2008 Jul; 27(29):4024-33. PubMed ID: 18317448
[TBL] [Abstract][Full Text] [Related]
16. p56lck activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus.
Matache C; Stefanescu M; Onu A; Tanaseanu S; Matei I; Frade R; Szegli G
Autoimmunity; 1999; 29(2):111-20. PubMed ID: 10433072
[TBL] [Abstract][Full Text] [Related]
17. A novel link between Lck, Bak expression and chemosensitivity.
Heyninck K; Beyaert R
Oncogene; 2006 Mar; 25(12):1693-5. PubMed ID: 16186791
[TBL] [Abstract][Full Text] [Related]
18. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.
Jiménez-Periañez A; Ojeda G; Criado G; Sánchez A; Pini E; Madrenas J; Rojo JM; Portolés P
J Leukoc Biol; 2005 Dec; 78(6):1386-96. PubMed ID: 16301324
[TBL] [Abstract][Full Text] [Related]
19. A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation.
Shi M; Cooper JC; Yu CL
Mol Cancer Res; 2006 Jan; 4(1):39-45. PubMed ID: 16446405
[TBL] [Abstract][Full Text] [Related]
20. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
